Tag: in vivo toxicology market share

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

In Vivo Toxicology Market Growth From $6 Billion In 2026 To $7.79 Billion By 2030 At A CAGR Of 6.7%

Significant growth has been observed in the in vivo toxicology market over recent years. It will grow from $5.61 billion in 2025 to $6 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. Historically, this expansion can be linked to factors such as the scarcity of standardized animal models, dependence on manual laboratory processes, an increase in pharmaceutical research and development endeavors, the rising occurrence of chronic disease investigations, and the adoption of fundamental imaging and analytical instruments.

The in vivo toxicology market is anticipated to show significant expansion in the coming years, with its size projected to reach $7.79 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This growth in the forecast period is primarily attributed to the development of genetically modified organisms for focused research, the integration of automated and high-throughput screening technologies, an increase in contract research organization (CRO) outsourcing for toxicology evaluations, advancements in in vivo imaging and monitoring solutions, and a growing emphasis on alternative testing methods and the reduction of animal testing. Significant trends expected during this period include a rising adoption of rodent and non-human primate models, an increased demand for advanced toxicology assay kits and reagents, the expansion of services for immunotoxicity and genotoxicity testing, the growing implementation of automated liquid handling and imaging systems, and heightened regulatory compliance and ethical standards in animal testing.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=15364670&type=smp&name=In%20Vivo%20Toxicology%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Vivo Toxicology Market Growth Factors: What’s Supporting Expansion?

A rising volume of drug discoveries is anticipated to drive expansion in the in vivo toxicology market moving ahead. Drug discovery encompasses the scientific process of identifying and designing novel compounds with potential as treatments or preventative measures for a range of ailments. Advances in biotechnology have greatly accelerated this process by improving comprehension of disease mechanisms and facilitating the development of more specific treatments. In vivo toxicology plays a crucial role in drug discovery, allowing for the assessment of the safety profile, tolerability, and any potential negative effects of compounds under investigation within intact organisms. It assists in pinpointing toxicities that limit dosage and guides decisions on formulation and dosing approaches before clinical trials begin. As an example, in November 2024, the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, reported that more than 12,000 new medicines were undergoing clinical trials in 2023, which was an increase from approximately 9,000 in 2022. Oncology made up 33% of this pipeline, while infectious diseases accounted for 13% and central nervous system diseases for 12%. Consequently, the expanding volume of drug discoveries is stimulating the expansion of the in vivo toxicology market.

In Vivo Toxicology Market Breakdown By Product Type And Application

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

In Vivo Toxicology Market Industry Trends: What’s Reshaping Demand?

Leading companies within the in vivo toxicology market are concentrating on developing sophisticated solutions, particularly secure cloud-based real-time data platforms, to enhance study management and accelerate decision-making. These secure platforms allow researchers and clients to access toxicology study data, milestones, planning tools, and essential documents remotely and securely, thereby improving collaboration and transparency. For instance, in March 2023, Charles River Laboratories International Inc., a US-based contract research organization, introduced Apollo, a secure cloud-based platform designed to offer real-time access to toxicology study data. This secure, cloud-based platform is specifically built to support in vivo general toxicology studies, providing instruments for data visualization, planning, and milestone tracking. It facilitates quicker and more informed decisions through immediate access to vital study information. Furthermore, the platform assists in streamlining project planning and budget estimation throughout the entire drug development process. By digitizing toxicology workflows, Apollo significantly boosts precision, efficiency, and collaboration in in vivo research.

In Vivo Toxicology Market Company Landscape And Competitive Strategy

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

View The Full In Vivo Toxicology Market Report:

https://thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Vivo Toxicology Market Regional Breakdown: Where Is Demand Concentrated?

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

In Vivo Toxicology Market Size, Value And Growth Trends Through 2030

The in vivo toxicology market has experienced substantial growth in recent years. Valued at $5.61 billion in 2025, it is projected to reach $6 billion by 2026, reflecting a compound annual growth rate (CAGR) of 7.0%. This historical expansion was driven by several factors, including a scarcity of standardized animal models, dependence on manual laboratory techniques, heightened pharmaceutical research and development efforts, a rising frequency of chronic disease investigations, and the integration of fundamental imaging and analytical tools.

The in vivo toxicology market is projected to experience robust expansion over the coming years, reaching a valuation of $7.79 billion by 2030 at a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is largely driven by the development of genetically modified organisms tailored for targeted research, the incorporation of automated and high-throughput screening platforms, an increase in CRO outsourcing for toxicology assessments, progress in in vivo imaging and monitoring technologies, and a heightened emphasis on alternative models alongside efforts to reduce animal testing. Among the key trends shaping this period are the growing reliance on rodent and non-human primate models, a rising demand for sophisticated toxicology assay kits and reagents, the broadening of immunotoxicity and genotoxicity testing offerings, the wider adoption of automated liquid handling and imaging systems, and stricter regulatory compliance combined with more robust animal welfare standards.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

In Vivo Toxicology Market Growth Momentum: Which Factors Are Influencing Demand?

The rising volume of drug discoveries is anticipated to drive expansion in the in vivo toxicology market moving forward. Drug discovery refers to the scientific process of identifying and designing new compounds that could potentially serve as treatments or preventive measures for various ailments. Advances in biotechnology have significantly accelerated this process by deepening comprehension of disease mechanisms and facilitating the development of more targeted therapies. In vivo toxicology plays a critical role in drug discovery, as it allows for the assessment of safety, tolerability, and possible adverse effects of investigational substances within whole organisms. It aids in detecting dose-limiting toxicities and guides formulation and dosing strategies before clinical trials begin. For example, in November 2024, the Patented Medicine Prices Review Board (PMPRB), a Canadian government agency, reported that over 12,000 new medicines were being tested in clinical trials in 2023, an increase from approximately 9,000 in 2022, with oncology comprising 33% of the pipeline, while infectious and central nervous system diseases accounted for 13% and 12%, respectively. Consequently, the growing number of drug discoveries is fueling the in vivo toxicology market’s growth.

In Vivo Toxicology Market Segment Landscape And Growth Potential

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

In Vivo Toxicology Market Trends Reshaping Industry Growth

Major players in the in vivo toxicology sector are concentrating on creating cutting-edge solutions, including secure cloud-based real-time data platforms, to optimize study management and accelerate decision-making processes. These platforms enable researchers and clients to remotely and securely access toxicology study data, milestones, planning tools, and documents, thereby boosting collaboration and transparency. For example, in March 2023, Charles River Laboratories International Inc., a contract research organization based in the US, unveiled Apollo—a secure cloud-based platform that offers real-time access to toxicology study data. This cloud-based, secure system is tailored to support in vivo general toxicology studies, featuring tools for data visualization, planning, and milestone tracking. It facilitates faster and more informed decisions by delivering real-time access to essential study data. Additionally, the platform streamlines project planning and budget estimation throughout the drug development process. By digitizing toxicology workflows, Apollo improves precision, efficiency, and collaboration in in vivo research.

In Vivo Toxicology Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

Access The Complete In Vivo Toxicology Market Report:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

In Vivo Toxicology Market Regional Analysis: Which Region Leads By Revenue?

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The In Vivo Toxicology Market In 2026 And How Much Will It Reach By 2030?

The in vivo toxicology market has experienced significant growth over recent years. It is anticipated to expand from $5.61 billion in 2025 to $6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. This market’s historical expansion can be attributed to several factors including the limited availability of standardized animal models, a reliance on manual laboratory procedures, increasing pharmaceutical research and development activities, a rise in chronic disease studies, and the adoption of basic imaging and analytical instruments.

The in vivo toxicology market size is projected for significant expansion over the coming years. It is anticipated to reach $7.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period is propelled by factors such as the creation of genetically modified organisms for specific research, the incorporation of automated and rapid screening systems, the increasing outsourcing of toxicology testing to Contract Research Organizations (CROs), advancements in in vivo imaging and monitoring methods, and a growing emphasis on alternative models alongside efforts to reduce animal testing. Key trends emerging in this period include the wider use of rodent and non-human primate models, a growing need for sophisticated toxicology assay kits and reagents, the broadening of services for immunotoxicity and genotoxicity testing, increased deployment of automated liquid handling and imaging technologies, and strengthened regulatory adherence and ethical principles in animal testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

What Major Growth Factors Are Impacting The In Vivo Toxicology Market?

The expanding volume of drug discoveries is anticipated to drive the advancement of the in vivo toxicology market in the future. This process, known as drug discovery, entails the scientific identification and creation of novel compounds designed to treat or prevent a range of illnesses. Advances in biotechnology have substantially accelerated this endeavor by deepening insights into disease mechanisms and facilitating the development of more specific therapeutic approaches. Within drug discovery, in vivo toxicology plays a crucial role by allowing for the assessment of safety, tolerability, and potential undesirable effects of experimental compounds within living organisms. It aids in pinpointing toxicities that limit dosage and guides the formulation and administration strategies before clinical trials commence. Illustratively, data from November 2024, provided by the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, indicated that more than 12,000 new medicines were undergoing clinical trials in 2023, marking an increase from approximately 9,000 in 2022. Of these, oncology comprised 33% of the drug pipeline, while infectious diseases constituted 13% and central nervous system diseases accounted for 12%. Consequently, the rising volume of drug discoveries is a primary driver behind the expansion of the in vivo toxicology market.

How Is The In Vivo Toxicology Market Examined Through Segment Analysis?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

Which Trends Are Expected To Shape The In Vivo Toxicology Market?

Leading firms within the in vivo toxicology market are concentrating on creating sophisticated tools, specifically secure cloud-based real-time data platforms, to optimize study administration and accelerate decision-making processes. These secure cloud-based platforms enable both researchers and clients to securely and remotely access toxicology study information, progress markers, planning utilities, and related documents, thereby fostering greater cooperation and openness. A notable illustration occurred in March 2023, when Charles River Laboratories International Inc., a contract research organization based in the US, introduced Apollo, its own secure cloud platform tailored for instant access to toxicology study details. This particular platform is cloud-based and secure, built to facilitate general in vivo toxicology studies by offering instruments for visualizing data, planning, and monitoring key milestones. By furnishing immediate access to vital study information, it facilitates faster and better-informed choices. Furthermore, the platform contributes to simplifying project planning and budget forecasting across the entire drug development lifecycle. Through the digitalization of toxicology workflows, Apollo significantly boosts accuracy, operational efficiency, and collaborative efforts in in vivo investigations.

Who Are The Prominent Players Across The In Vivo Toxicology Market?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

Access The Complete In Vivo Toxicology Market Report:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Region Leads The In Vivo Toxicology Market By Size?

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access In Vivo Toxicology Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The In Vivo Toxicology Market Compare Between 2026 And 2030?

The in vivo toxicology market has experienced substantial expansion in recent years. This market is projected to grow from $5.61 billion in 2025 to $6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be attributed to factors such as the limited availability of standardized animal models, reliance on manual laboratory procedures, increasing pharmaceutical R&D activities, the rising prevalence of chronic disease studies, and the adoption of basic imaging and analytical instruments.

The in vivo toxicology market size is anticipated to show significant expansion in the coming years, with its value expected to reach $7.79 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%. This projected growth during the forecast period is driven by factors such as the development of genetically modified organisms for targeted research, the integration of automated and high-throughput screening systems, an increase in CRO outsourcing for toxicology testing, advancements in in vivo imaging and monitoring technologies, and a rising focus on alternative models and the reduction of animal testing. Major trends foreseen for the forecast period include the increasing adoption of rodent and non-human primate models, a growing demand for advanced toxicology assay kits and reagents, the expansion of immunotoxicity and genotoxicity testing services, increased utilization of automated liquid handling and imaging systems, and enhanced regulatory compliance and ethical standards in animal testing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

What Primary Drivers Are Shaping The In Vivo Toxicology Market?

The in vivo toxicology market is projected to expand due to the rising volume of drug discoveries. This process entails the scientific identification and design of novel compounds intended for disease treatment or prevention. Advances in biotechnology have greatly accelerated drug discovery by improving disease understanding and facilitating the development of more precise therapies. In drug discovery, in vivo toxicology plays a crucial role, allowing for the assessment of safety, tolerability, and possible side effects of experimental compounds within entire living organisms. It aids in pinpointing toxicities that limit dosage and guides the formulation and dosing strategies before clinical trials begin. For example, in November 2024, data from the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, indicated that more than 12,000 new medicines were undergoing clinical trials in 2023, a notable increase from approximately 9,000 in 2022. Of these, oncology comprised 33% of the development pipeline, while infectious and central nervous system diseases accounted for 13% and 12%, respectively. Consequently, the increasing volume of drug discoveries is fueling the expansion of the in vivo toxicology market.

How Are Segments Identified Within The In Vivo Toxicology Market Segment Framework?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

What Market Trends Are Affecting The In Vivo Toxicology Market?

Major companies in the in vivo toxicology market are prioritizing the development of advanced solutions, including secure cloud-based real-time data platforms, to streamline study management and enhance the speed of decision-making. These platforms enable researchers and clients to securely and remotely access toxicology study data, milestones, planning tools, and documents, thereby fostering improved collaboration and transparency. For instance, in March 2023, Charles River Laboratories International Inc., a US-based contract research organization, launched Apollo, a secure cloud-based platform providing real-time access to toxicology study data. This platform is designed to support in vivo general toxicology studies with features for data visualization, planning, and milestone tracking. By offering real-time access to critical study information, it facilitates quicker and more informed decisions. The platform further assists in optimizing project planning and budget estimation throughout the drug development process, ultimately boosting precision, efficiency, and collaboration in in vivo research through the digitization of toxicology workflows.

Who Are The Companies Competing Within The In Vivo Toxicology Market?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

Get The Full In Vivo Toxicology Market Report:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Geographic Region Dominates The In Vivo Toxicology Market?

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized In Vivo Toxicology Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The In Vivo Toxicology Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The in vivo toxicology market size has experienced robust expansion in recent years. This market is projected to expand from $5.61 billion in 2025 to reach $6 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to its historical growth include the scarcity of standardized animal models, dependence on manual laboratory processes, heightened pharmaceutical research and development endeavors, the rising occurrence of chronic disease investigations, and the incorporation of fundamental imaging and analytical instruments.

The in vivo toxicology market is anticipated to experience substantial expansion in the coming years. Its value is projected to reach $7.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This projected growth during the forecast period stems from factors such as the creation of genetically modified organisms for specific research, the incorporation of automated and rapid screening technologies, an increase in CRO outsourcing for toxicology assessments, innovations in in vivo imaging and tracking methods, and a greater emphasis on alternative testing models coupled with a reduction in animal experimentation. Key developments anticipated in this period encompass a heightened utilization of rodent and non-human primate models, an escalating need for sophisticated toxicology assay kits and reagents, the broadening of immunotoxicity and genotoxicity evaluation services, a surge in the application of automated liquid handling and imaging solutions, and improved adherence to regulatory and ethical guidelines for animal testing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

What Major Drivers Are Influencing Demand In The In Vivo Toxicology Market?

The rising volume of drug discoveries is projected to fuel the expansion of the in vivo toxicology market moving ahead. Drug discovery entails the scientific identification and development of novel compounds intended as treatments or preventive measures for diverse illnesses. Advances in biotechnology have greatly accelerated this process by improving comprehension of disease mechanisms and facilitating the development of more precise treatments. Within drug discovery, in vivo toxicology plays a crucial role by allowing for the assessment of safety, tolerability, and any prospective negative impacts of experimental compounds within living organisms. This practice aids in pinpointing toxicities that limit dosage and guides the formulation and dosage approaches before clinical trials begin. As an illustration, in November 2024, data from the Patented Medicine Prices Review Board (PMPRB), a government agency based in Canada, revealed that more than 12,000 new medicines were undergoing clinical trials in 2023, an increase from approximately 9,000 in 2022. Of these, oncology comprised 33% of the development pipeline, while infectious and central nervous system diseases constituted 13% and 12%, respectively. Consequently, the expanding volume of drug discoveries is propelling the advancement of the in vivo toxicology market.

What Major Segment Divisions Exist Within The In Vivo Toxicology Market?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

How Are Trends Shaping The Direction Of The In Vivo Toxicology Market?

Major companies in the in vivo toxicology market are increasingly focused on developing advanced solutions, such as secure cloud-based real-time data platforms, to optimize study management and accelerate decision-making. These secure cloud-based platforms offer researchers and clients remote and secure access to toxicology study data, milestones, planning tools, and documents, thereby improving collaboration and transparency. For example, in March 2023, Charles River Laboratories International Inc., a US-based contract research organization, launched Apollo, a secure cloud-based platform specifically designed to provide real-time access to toxicology study data. This platform supports in vivo general toxicology studies with integrated tools for data visualization, planning, and milestone tracking. It facilitates quicker and more informed decisions by offering instant access to essential study information. The platform also aids in streamlining project planning and budget estimation throughout the drug development process. By digitizing toxicology workflows, Apollo enhances precision, efficiency, and collaborative efforts in in vivo research.

Which Companies Are Leading Innovation In The In Vivo Toxicology Market?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

Read the full in vivo toxicology market report here:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The In Vivo Toxicology Market?

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored In Vivo Toxicology Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the in vivo toxicology market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the In Vivo Toxicology Market show for the 2026–2030 period?

The in vivo toxicology market size has demonstrated significant growth in recent years. This market is set to expand from $5.61 billion in 2025 to $6 billion in 2026, registering a compound annual growth rate (CAGR) of 7.0%. Historically, this growth can be ascribed to factors including the restricted availability of standardized animal models, a dependence on manual laboratory procedures, increasing pharmaceutical R&D activities, the rising occurrence of chronic disease studies, and the adoption of basic imaging and analytical instruments.

The in vivo toxicology market size is projected to experience substantial expansion in the coming years, reaching $7.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This anticipated growth during the forecast period is due to factors such as the creation of genetically modified organisms for precise research, the incorporation of automated and high-throughput screening solutions, increased CRO outsourcing for toxicology assessments, progress in in vivo imaging and monitoring techniques, and a greater emphasis on alternative models along with the reduction of animal testing. Key developments expected in this period include the increased acceptance of rodent and non-human primate models, a growing need for sophisticated toxicology assay kits and reagents, the broadening of immunotoxicity and genotoxicity testing offerings, the wider implementation of automated liquid handling and imaging systems, and stricter regulatory adherence and ethical benchmarks in animal testing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

What Drivers Are Shaping The Development Of The In Vivo Toxicology Market?

The expanding volume of drug discoveries is projected to stimulate the growth of the in vivo toxicology market moving forward. Drug discovery entails the scientific identification and creation of new substances that can serve as therapies or preventive measures for various ailments. Progress in biotechnology has considerably boosted this endeavor by deepening the understanding of disease mechanisms and enabling the development of more targeted interventions. In vivo toxicology is indispensable in drug discovery, facilitating the evaluation of investigational compounds’ safety, tolerability, and potential adverse reactions within whole organisms. It aids in pinpointing dose-limiting toxicities and provides critical input for formulation and dosing strategies ahead of clinical development. For instance, in November 2024, according to the Patented Medicine Prices Review Board (PMPRB), a Canada-based government agency, over 12,000 new medicines were in clinical trials in 2023, an increase from around 9,000 in 2022, with oncology making up 33% of the pipeline, and infectious and central nervous system diseases comprising 13% and 12%, respectively. Therefore, the increasing pace of drug discoveries is a key factor propelling the expansion of the in vivo toxicology market.

What Segment Types Are Examined In The In Vivo Toxicology Market?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

Which Trends Are Influencing The Development Of The In Vivo Toxicology Market?

Leading companies operating in the in vivo toxicology market are concentrating on creating advanced solutions, particularly secure cloud-based real-time data platforms, to streamline study management and enhance the speed of decision-making. These secure cloud-based real-time data platforms enable researchers and clients to access toxicology study data, milestones, planning tools, and various documents remotely and securely, thereby fostering improved collaboration and transparency. As an illustration, in March 2023, Charles River Laboratories International Inc., a US-based contract research organization, introduced Apollo, a secure cloud-based platform engineered to offer real-time access to toxicology study data. This secure, cloud-based platform is designed to support in vivo general toxicology studies, incorporating features for data visualization, planning, and milestone tracking. It facilitates faster and more informed decisions by providing instantaneous access to critical study data. The platform also assists in streamlining project planning and budget estimation throughout the drug development process. By digitizing toxicology workflows, Apollo considerably improves precision, efficiency, and collaboration in in vivo research.

Who Are The Core Companies Influencing Trends In The In Vivo Toxicology Market?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., Transcure Bioservices Pvt. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Regions Are Projected To Dominate The In Vivo Toxicology Market In The Coming Years?

North America was the largest region in the in-vivo toxicology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized In Vivo Toxicology Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The In Vivo Toxicology Industry By The Forecast Year 2029?

The in-vivo toxicology market has experienced significant growth in recent years. It is anticipated to expand from $5.24 billion in 2024 to $5.61 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. This historical growth can be attributed to the increasing demand for GLP-compliant studies, the broadening of reach regulations, the rise in biologics and biosimilars requiring safety assessments, greater investment in oncology drug development, and the expansion of gene and cell therapy pipelines.

The in-vivo toxicology market is projected to experience robust expansion over the coming years, reaching $7.31 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast period is fueled by several factors, including an increase in global drug development initiatives, a heightened demand for personalized medicine, a greater number of clinical trials, pharmaceutical companies’ increased outsourcing of toxicology testing, and heightened consumer safety concerns regarding food and personal care items. Key trends expected during this period encompass the creation of sophisticated animal models, the incorporation of imaging technologies into in vivo research, the rise of automated data collection mechanisms, the application of AI and ML for analyzing toxicology data, and advancements in animal telemetry and biomarker identification.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

What Are The Top Growth Drivers Impacting The In Vivo Toxicology Market Outlook?

The escalating volume of drug discoveries is anticipated to fuel the expansion of the in vivo toxicology market moving forward. Drug discovery is defined as the scientific process of identifying and designing new compounds that can act as treatments or preventatives for various conditions. Advancements in biotechnology have significantly propelled this process by enhancing our comprehension of disease mechanisms and enabling the development of more targeted therapies. In this context, in vivo toxicology is indispensable, providing the means to assess the safety, tolerability, and potential adverse reactions of investigational compounds within whole organisms. It is instrumental in identifying dose-limiting toxicities and informing strategies for formulation and dosing before compounds advance to clinical development. As an illustration, in May 2025, a report from the Government of Canada, a Canada-based constitutional body, revealed that the worldwide count of medicines in clinical development reached 10,134 in March 2025, marking a 20% growth compared to September 2021. Thus, the growing number of drug discoveries is a primary driver for the in vivo toxicology market’s growth.

Which Key Segments Fueling The In Vivo Toxicology Market?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

What Trends Are Expected To Drive The In Vivo Toxicology Market?

Leading firms within the in vivo toxicology market are concentrating on creating sophisticated solutions, including secure cloud-based real-time data platforms, aiming to optimize study management and accelerate decision-making processes. These secure cloud-based real-time data platforms facilitate remote and secure access for researchers and clients to toxicology study data, key milestones, planning utilities, and documentation, thereby fostering improved collaboration and transparency. An example of this is the launch of Apollo in March 2023 by Charles River Laboratories International Inc., a US-based contract research organization. Apollo is a secure cloud-based platform specifically designed to offer real-time access to toxicology study data. This particular platform is a secure, cloud-based system intended to assist in vivo general toxicology studies, providing instruments for data visualization, planning, and tracking significant milestones. By furnishing real-time access to crucial study data, it facilitates faster and more well-informed decision-making. Furthermore, the platform aids in streamlining both project planning and budget estimations across the entire drug development lifecycle. Through the digitization of toxicology workflows, Apollo significantly boosts precision, efficiency, and collaborative efforts within in vivo research.

Which Major Industry Participants Are Leading The In Vivo Toxicology Market Growth?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., SRI International, MatTek Corporation, Transcure Bioservices Pvt. Ltd., Altogen Labs.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The In Vivo Toxicology Market?

North America was the largest region in the in-vivo toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The In Vivo Toxicology Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

Browse Through More Reports Similar to the Global In Vivo Toxicology Market 2025, By The Business Research Company

In Vitro Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Adme Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Genetic Toxicology Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the In Vivo Toxicology Market Heading Into 2029?

The market for in-vivo toxicology has experienced significant growth in the past few years. It is projected to expand from $5.24 billion in 2024 to $5.61 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.1%. This historical growth can be attributed to various factors such as the increasing demand for studies that comply with Good Laboratory Practice (GLP), the broadening of reach regulations, an increase in biologics and biosimilars that require safety evaluations, more investment in the development of oncology drugs, and the proliferation of gene and cell therapy pipelines.

It is anticipated that the in-vivo toxicology market will experience robust growth in the forthcoming years, with the market value projected to reach $7.31 billion in 2029, registering a compound annual growth rate (CAGR) of 6.8%. This upward trend during the projection period can be associated with factors such as the escalating global activities in drug development, increasing demand for personalized healthcare, growth in clinical trials, the rise in toxicology testing outsourcing by pharmaceutical entities, and expanding consumer safety concerns in the food and personal care commodities sector. Key trend-shifts expected during the projection period encompass the creation of sophisticated animal models, the incorporation of imaging technologies into in-vivo studies, the advent of automated data gathering systems, the utilization of Artificial Intelligence (AI) and Machine Learning (ML) in analyzing toxicology data, and advancements in telemetry and biomarker identification in animals.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25791&type=smp

Which Factors Are Pushing The In Vivo Toxicology Market Forward?

The surge in drug discoveries is anticipated to fuel the expansion of the in vivo toxicology market. The process involves the scientific recognition and development of novel compounds that can potentially serve as remedies or prevention for various illnesses. The advancement in biotechnology has greatly improved this mechanism by improving comprehension of disease mechanisms and allowing for the creation of more specific therapies. An essential aspect of drug discovery, in vivo toxicology facilitates safety evaluation, tolerability and potential side effects of investigational compounds in entire organisms. It aids in identifying dose-limiting toxicities and contributes to formulating dosing plans before clinical development. For example, as per an article issued by the Government of Canada in May 2025, a Canada-based statutory body states that the number of medicines in clinical development globally reached 10,134 in March 2025, marking a 20% rise since September 2021. Thus, the escalating number of drug discoveries is propelling the growth of the in vivo toxicology market.

Which Segment Held The Largest Share In The In Vivo Toxicology Market In 2025?

The in vivo toxicology market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Testing Types: Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, Acute Toxicity Testing

3) By Methodology: In Vivo Animal Models, Genetically Modified Organisms, Non-Human Primate Studies, Rodent Models, Larger Mammals

4) By Application: Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental And Reproductive Toxicity (DART), Other Applications

5) By End-User: Pharmaceutical Companies, Biosimilars Manufacturers, Contract Research Organizations (CROs), Academic And Research Institutions, Biotechnology Firms

Subsegments:

1) By Consumables: Animal Models, Reagents And Kits, Assay Kits, Toxicology Testing Media, Antibodies, Biochemicals, Buffers And Solutions, Disposable Labware, Animal Feed, Diluents

2) By Instruments: Imaging Systems, Flow Cytometers, PCR Machines, Spectrophotometers, Microscopes, Analyzers, Centrifuges, Incubators, Animal Monitoring Systems, Automated Liquid Handling Systems

How Are Key Trends Driving Expansion In The In Vivo Toxicology Industry?

Major firms involved in the in vivo toxicology sector are revamping their strategies to create state-of-the-art solutions, like secure, real-time data platforms based on the cloud, in order to enhance study administration and speed up decision-making processes. These secure and cloud-managed platforms provide real-time access to study related data, planning resources, milestones, and documents, securely and remotely to both researchers and clients, thereby improving transparency and cooperation. Charles River Laboratories International Inc., an American contract research organization, unveiled Apollo – a secure and cloud-based platform for real-time access to toxicology study data, in March 2023. Apollo is designed to support general toxicology studies in vivo with data visualization, planning, and milestone tracking tools, enabling real-time access to essential study data, and hence, facilitating faster and better-informed decisions. It also aids in streamlining budget estimation and project planning throughout the drug development process. Apollo’s digitalization of toxicology workflows enhances precision, efficiency, and partnership during in vivo research.

Which Organizations Are Driving Progress In The In Vivo Toxicology Industry?

Major companies operating in the in vivo toxicology market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (Labcorp), Sigma-Aldrich Co. LLC, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Jubilant Life Sciences Limited, Evotec SE, The Jackson Laboratory, Inotiv Inc., SRI International, MatTek Corporation, Transcure Bioservices Pvt. Ltd., Altogen Labs.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vivo-toxicology-global-market-report

Which Region Is Expected To Experience The Highest Growth In The In Vivo Toxicology Industry?

North America was the largest region in the in-vivo toxicology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vivo toxicology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25791&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model